Cargando…
HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma
Heat-shock protein (HSP) 70 is aberrantly expressed in different malignancies and has a cancer-specific cell-protective effect. As such, it has emerged as a promising target for anticancer therapy. In this study, the effect of the HSP70-specific inhibitor (PES), also Pifitrin-μ, on primary effusion...
Autores principales: | Granato, M, Lacconi, V, Peddis, M, Lotti, L V, Renzo, L D, Gonnella, R, Santarelli, R, Trivedi, P, Frati, L, D'Orazi, G, Faggioni, A, Cirone, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730433/ https://www.ncbi.nlm.nih.gov/pubmed/23868063 http://dx.doi.org/10.1038/cddis.2013.263 |
Ejemplares similares
-
HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma
por: Granato, M, et al.
Publicado: (2014) -
JNK and Macroautophagy Activation by Bortezomib Has a Pro-Survival Effect in Primary Effusion Lymphoma Cells
por: Granato, Marisa, et al.
Publicado: (2013) -
Primary Effusion Lymphoma Cell Death Induced by Bortezomib and AG 490 Activates Dendritic Cells through CD91
por: Cirone, Mara, et al.
Publicado: (2012) -
Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line
por: Gonnella, Roberta, et al.
Publicado: (2013) -
Targeting of Prosurvival Pathways as Therapeutic Approaches against Primary Effusion Lymphomas: Past, Present, and Future
por: Granato, Marisa, et al.
Publicado: (2015)